These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28600754)

  • 1. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
    Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
    J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients.
    Gaither JR; Gordon K; Crystal S; Edelman EJ; Kerns RD; Justice AC; Fiellin DA; Becker WC
    Drug Alcohol Depend; 2018 Nov; 192():371-376. PubMed ID: 30122319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician Referrals for Non-opioid Pain Care Following Discontinuation of Long-term Opioid Therapy Differ Based on Reasons for Discontinuation.
    Lovejoy TI; Morasco BJ; Demidenko MI; Meath THA; Dobscha SK
    J Gen Intern Med; 2018 May; 33(Suppl 1):24-30. PubMed ID: 29633130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders.
    Lovejoy TI; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Dobscha SK
    Pain; 2017 Mar; 158(3):526-534. PubMed ID: 28192376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain.
    Appa A; McMahan VM; Long K; Shade SB; Coffin PO
    Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users.
    Demidenko MI; Dobscha SK; Morasco BJ; Meath THA; Ilgen MA; Lovejoy TI
    Gen Hosp Psychiatry; 2017 Jul; 47():29-35. PubMed ID: 28807135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
    Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
    Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.
    James JR; Scott JM; Klein JW; Jackson S; McKinney C; Novack M; Chew L; Merrill JO
    J Gen Intern Med; 2019 Dec; 34(12):2749-2755. PubMed ID: 31468341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
    Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
    J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study.
    Williams EC; Matson TE; Hallgren KA; Oliver M; Wang X; Bradley KA
    J Gen Intern Med; 2024 Sep; 39(12):2169-2178. PubMed ID: 38954321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
    Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
    BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
    Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
    Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.